Inbios Reagents
Closed Special Notice Posted
- Solicitation number
- 96463
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Georgia 30329, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services, has issued a Special Notice regarding the procurement of InBios DENV Detect IgM Capture Elisa Kit reagents. This notice indicates the CDC's intent to award a sole source, firm fixed price purchase order to InBios International, Inc., without conducting a competitive procurement. The award is being made under the authority of Revolutionary FAR Overhaul 6.103-1 (Sole Source Authority for Purchases). The product in question is classified under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets). This Special Notice was posted on March 12, 2026, and represents the CDC's official notification of its contracting intention.
The primary objective of this procurement is to obtain specialized diagnostic reagents for the CDC's ongoing dengue virus (DENV) surveillance program at the Dengue Branch Diagnostic Laboratory. The InBios DENV Detect IgM Capture Elisa Kit is the sole FDA-approved serology test for dengue diagnosis, justifying the sole source award. Interested contractors have until March 27, 2026, at 5:00 PM EST to submit quotations or responses via email to the contract specialist at qsx8@cdc.gov. Although this is not a competitive solicitation, all responses received within 15 days of the notice's issuance will be considered by the government for evaluation purposes. The government retains sole discretion in determining whether to proceed with the sole source award or initiate a competitive procurement based on received responses. While no formal set-asides have been designated, interested parties in diagnostic reagent manufacturing are encouraged to respond.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to InBios International, Inc. for InBios DENV Detect TM IgM Capture Elisa Kit. The InBios DENV Detect TM IgM Capture Elisa Kit is the only serology test approved by the FDA for dengue diagnosis. This test is performed as part of the ongoing DENV surveillance program at the Dengue Branch Diagnostic Laboratory. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of Revolutionary FAR Overhaul 6.103-1 (SAP).
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email qsx8@cdc.gov by March 27, 2026 before 5pm EST.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity